MindX Sciences Logo


Indianapolis, IN, April 8th, 2021 — IU School of Medicine researchers develop blood test for depression, bipolar disorder.  View more...

Indianapolis, IN, March 9th, 2021 — Dr. Christopher Reist, an authority on PTSD and clinical trials, joined the Scientific Advisory Board (SAB) of MindX Sciences.

Indianapolis, IN, March 8th, 2021 — Dr. Alexander Niculescu gave a talk on “Precision Medicine for Mood Disorders”, an upcoming publication, at the annual invitation-only Translational Psychiatry meeting in Park City, Utah, this year held in a virtual format.

Indianapolis, IN, March 2nd, 2021 — MindX Sciences Inc. and Q2 Solutions announced today that they have reached an agreement, whereas Q2 Solutions will be doing the CLIA laboratory genomic work for MindX Sciences blood tests. Initial offered tests include mood disorders (depression/bipolar), pain, PTSD, suicidality, memory disorders, and longevity.

Indianapolis, IN, February 26th, 2021 — The United States Patent Office granted Patent Application No. 15/735,304 titled: PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT, licensed by MindX Sciences from Indiana University.

Can An Indy Startup Conquer Mental Health’s Final Frontier?

Indianapolis Monthly, March 2021